Open AccessSeven-day triple therapy is a better choice forHelicobacter pylorieradication in regions with low antibiotic resistance
Author(s) -
Yue-Feng Tong
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i46.13073
Subject(s) - levofloxacin , clarithromycin , amoxicillin , helicobacter pylori , medicine , antibiotics , antibiotic resistance , gastroenterology , agar dilution , breath test , urea breath test , microbiology and biotechnology , helicobacter pylori infection , minimum inhibitory concentration , biology
To investigate whether 7-d triple therapies are still valid in populations with low levels of resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom